Athenex, Inc. (ATNX): Price and Financial Metrics
Athenex, Inc. (ATNX)
Today's Latest Price: $12.39 USD
Updated Sep 25 4:00pm
Add ATNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATNX Stock Summary
- ATNX's went public 3.29 years ago, making it older than just 10.86% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 71.81%, Athenex Inc's debt growth rate surpasses 84.45% of about US stocks.
- As for revenue growth, note that ATNX's revenue has grown 61.5% over the past 12 months; that beats the revenue growth of 91.74% of US companies in our set.
- Stocks that are quantitatively similar to ATNX, based on their financial statements, market capitalization, and price volatility, are RTRX, PFNX, BLDP, UTSI, and KMDA.
- Visit ATNX's SEC page to see the company's official filings. To visit the company's web site, go to www.athenex.com.
ATNX Stock Price Chart Technical Analysis Charts
ATNX Price/Volume Stats
| Current price | $12.39 | 52-week high | $18.35 |
| Prev. close | $11.81 | 52-week low | $5.63 |
| Day low | $12.00 | Volume | 716,412 |
| Day high | $12.48 | Avg. volume | 704,140 |
| 50-day MA | $11.80 | Dividend yield | N/A |
| 200-day MA | $11.93 | Market Cap | 1.01B |
Athenex, Inc. (ATNX) Company Bio
Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.
Loading social stream, please wait...